SAMANTHA HUGHES: Open Payments
NPI 1578135679 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 68 payments from 10 companies in 2025. Trend: 2023 $650 · 2024 $2,733 · 2025 $1,539
Food & beverage: $1,539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $684 |
| Amgen Inc. | 14 | $287 |
| Novartis Pharmaceuticals Corporation | 18 | $217 |
| UCB, Inc. | 6 | $116 |
| AstraZeneca Pharmaceuticals LP | 3 | $77 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| PFIZER INC. | 1 | $23 |
| Radius Health, Inc. | 1 | $23 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Neurelis, Inc. | 1 | $20 |
Products named: RINVOQ, SKYRIZI, COSENTYX, TAVNEOS, Bimzelx, SAPHNELO, BENLYSTA, Otezla.
Industry payments across CA — which companies pay providers there.
